• March 11, 2021
• 0
• Category:
  • Breaking News
  • Cancer
  • Health Tips
  • Treatment Innovation
• Tags: Treatment Innovation

According Aveo Oncology, The Food and Drug Administration (FDA) on 10th March 2021 approved Fotivda (tivozanib) for the treatment of adults with relapsed or refractory advanced kidney cancer (renal cell...

• January 6, 2021
• 0
• Category:
  • Blogs
  • Breaking News
  • Business
• Tags: covid-19covid-19 resource

Share on facebook Share on twitter Share on linkedin Share on whatsapp Share on email Share on print As 2020 comes to a close, our Managing Director, Krishan Kumar, reflects...

• January 26, 2020
• 0
• Category:
  • Blogs
  • Breaking News
  • Business
• Tags: No Tag